Efficacy, Safety and Immunogenicity of Sun’s Ranibizumab Biosimilar in Neovascular Age-Related Macular Degeneration: A Phase 3, Double-Blind Comparative Study
Article in Ophthalmology and Therapy (March 2024)
The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.
Article in Ophthalmology and Therapy (March 2024)
Book chapter (February 2024)
Article in Clinical Ophthalmology (April 2023)